Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

NCT02727582 · clinicaltrials.gov ↗
COMPLETED
Status
142
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University of Cape Town

Collaborators